Thalidomide‐induced teratogenesis: History and mechanisms
Publication type: Journal Article
Publication date: 2015-06-04
SJR: —
CiteScore: —
Impact factor: —
ISSN: 1542975X, 15429768
PubMed ID:
26043938
General Medicine
Developmental Biology
Embryology
Abstract
Nearly 60 years ago thalidomide was prescribed to treat morning sickness in pregnant women. What followed was the biggest man-made medical disaster ever, where over 10,000 children were born with a range of severe and debilitating malformations. Despite this, the drug is now used successfully to treat a range of adult conditions, including multiple myeloma and complications of leprosy. Tragically, a new generation of thalidomide damaged children has been identified in Brazil. Yet, how thalidomide caused its devastating effects in the forming embryo remains unclear. However, studies in the past few years have greatly enhanced our understanding of the molecular mechanisms the drug. This review will look at the history of the drug, and the range and type of damage the drug caused, and outline the mechanisms of action the drug uses including recent molecular advances and new findings. Some of the remaining challenges facing thalidomide biologists are also discussed.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Reproductive Toxicology
16 publications, 2.2%
|
|
|
Scientific Reports
9 publications, 1.24%
|
|
|
International Journal of Molecular Sciences
8 publications, 1.1%
|
|
|
Pharmaceuticals
8 publications, 1.1%
|
|
|
Birth Defects Research
8 publications, 1.1%
|
|
|
Chirality
6 publications, 0.83%
|
|
|
Journal of Hand Surgery: European Volume
5 publications, 0.69%
|
|
|
Clinical Therapeutics
5 publications, 0.69%
|
|
|
Expert Opinion on Drug Safety
5 publications, 0.69%
|
|
|
Oncotarget
4 publications, 0.55%
|
|
|
Small
4 publications, 0.55%
|
|
|
Cancers
4 publications, 0.55%
|
|
|
Drug Safety
4 publications, 0.55%
|
|
|
Drug Discovery Today
4 publications, 0.55%
|
|
|
Trends in Molecular Medicine
4 publications, 0.55%
|
|
|
British Journal of Clinical Pharmacology
4 publications, 0.55%
|
|
|
Journal of Chemical Education
4 publications, 0.55%
|
|
|
BMJ Open
4 publications, 0.55%
|
|
|
Cells
3 publications, 0.41%
|
|
|
International Journal of Environmental Research and Public Health
3 publications, 0.41%
|
|
|
Frontiers in Cell and Developmental Biology
3 publications, 0.41%
|
|
|
Archives of Toxicology
3 publications, 0.41%
|
|
|
Therapeutic Innovation and Regulatory Science
3 publications, 0.41%
|
|
|
Journal of Pharmacokinetics and Pharmacodynamics
3 publications, 0.41%
|
|
|
Nature Chemical Biology
3 publications, 0.41%
|
|
|
Bioorganic Chemistry
3 publications, 0.41%
|
|
|
PLoS ONE
3 publications, 0.41%
|
|
|
European Journal of Pharmaceutical Sciences
3 publications, 0.41%
|
|
|
Cell Chemical Biology
3 publications, 0.41%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
20
40
60
80
100
120
140
160
180
|
|
|
Elsevier
180 publications, 24.76%
|
|
|
Springer Nature
108 publications, 14.86%
|
|
|
Wiley
102 publications, 14.03%
|
|
|
MDPI
48 publications, 6.6%
|
|
|
Taylor & Francis
33 publications, 4.54%
|
|
|
American Chemical Society (ACS)
28 publications, 3.85%
|
|
|
SAGE
25 publications, 3.44%
|
|
|
Oxford University Press
17 publications, 2.34%
|
|
|
Frontiers Media S.A.
13 publications, 1.79%
|
|
|
Royal Society of Chemistry (RSC)
12 publications, 1.65%
|
|
|
Cold Spring Harbor Laboratory
12 publications, 1.65%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
11 publications, 1.51%
|
|
|
Bentham Science Publishers Ltd.
8 publications, 1.1%
|
|
|
Public Library of Science (PLoS)
7 publications, 0.96%
|
|
|
BMJ
6 publications, 0.83%
|
|
|
Impact Journals
4 publications, 0.55%
|
|
|
Cambridge University Press
4 publications, 0.55%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.41%
|
|
|
Spandidos Publications
3 publications, 0.41%
|
|
|
Georg Thieme Verlag KG
3 publications, 0.41%
|
|
|
IntechOpen
3 publications, 0.41%
|
|
|
Annual Reviews
3 publications, 0.41%
|
|
|
American Society for Clinical Investigation
2 publications, 0.28%
|
|
|
The Company of Biologists
2 publications, 0.28%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 0.28%
|
|
|
Japanese Society of Toxicology
2 publications, 0.28%
|
|
|
American Association for Cancer Research (AACR)
2 publications, 0.28%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 0.28%
|
|
|
Pleiades Publishing
2 publications, 0.28%
|
|
|
20
40
60
80
100
120
140
160
180
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
727
Total citations:
727
Citations from 2024:
167
(22.97%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Vargesson N. Thalidomide‐induced teratogenesis: History and mechanisms // Birth Defects Research Part C Embryo Today Reviews. 2015. Vol. 105. No. 2. pp. 140-156.
GOST all authors (up to 50)
Copy
Vargesson N. Thalidomide‐induced teratogenesis: History and mechanisms // Birth Defects Research Part C Embryo Today Reviews. 2015. Vol. 105. No. 2. pp. 140-156.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1002/bdrc.21096
UR - https://doi.org/10.1002/bdrc.21096
TI - Thalidomide‐induced teratogenesis: History and mechanisms
T2 - Birth Defects Research Part C Embryo Today Reviews
AU - Vargesson, Neil
PY - 2015
DA - 2015/06/04
PB - Wiley
SP - 140-156
IS - 2
VL - 105
PMID - 26043938
SN - 1542-975X
SN - 1542-9768
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2015_Vargesson,
author = {Neil Vargesson},
title = {Thalidomide‐induced teratogenesis: History and mechanisms},
journal = {Birth Defects Research Part C Embryo Today Reviews},
year = {2015},
volume = {105},
publisher = {Wiley},
month = {jun},
url = {https://doi.org/10.1002/bdrc.21096},
number = {2},
pages = {140--156},
doi = {10.1002/bdrc.21096}
}
Cite this
MLA
Copy
Vargesson, Neil. “Thalidomide‐induced teratogenesis: History and mechanisms.” Birth Defects Research Part C Embryo Today Reviews, vol. 105, no. 2, Jun. 2015, pp. 140-156. https://doi.org/10.1002/bdrc.21096.